Compare ABOS & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABOS | RDCM |
|---|---|---|
| Founded | 1996 | 1985 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.0M | 205.1M |
| IPO Year | 2021 | 1999 |
| Metric | ABOS | RDCM |
|---|---|---|
| Price | $2.58 | $16.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $8.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 294.2K | 216.2K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.50 |
| Revenue Next Year | N/A | $9.74 |
| P/E Ratio | ★ N/A | $16.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.97 | $10.41 |
| 52 Week High | $3.60 | $16.74 |
| Indicator | ABOS | RDCM |
|---|---|---|
| Relative Strength Index (RSI) | 49.42 | 73.22 |
| Support Level | $2.24 | $12.39 |
| Resistance Level | $3.02 | $16.49 |
| Average True Range (ATR) | 0.14 | 0.79 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 43.64 | 84.01 |
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.